Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenocarcinoma of Lung × osimertinib × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 14 Lung Neoplasms 8 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Carcinoma 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Stage II-IIIB Non-small Cell Lung Carcinoma 1 Squamous Cell Carcinoma of Head and Neck 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma 1 Hematologic Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Carboplatin 4 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 fludarabine phosphate 2 Taxes 2 Radiotherapy 2 Radiation 2 Paclitaxel 2 Cyclophosphamide 2 Biopsy 2 veliparib 1 pembrolizumab 1 methoxyamine 1 fludarabine 1 durvalumab 1 dapagliflozin 1 capmatinib 1 aldesleukin 1 Standard of Care 1 Smoking Devices 1 Radiotherapy, Image-Guided 1 Radiotherapy, Conformal 1 Radiosurgery 1 Practice Guidelines as Topic 1 Platinum 1 Pemetrexed 1 Nivolumab 1 Ipilimumab 1 Interleukin-2 1 Interleukin-13 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡